Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03874585 · ClinicalTrials.gov registry record · Phase 1
Text Messaging-Based Smoking Cessation Program for Homeless Youth
A Phase 1 study of Cigarette Smoking, sponsored by RAND.
- Completed
- Registry status
- Phase 1
- Development phase
- 77
- Enrollment target
- 3
- Study locations
NCT03874585: Completed Phase 1 study of Cigarette Smoking, sponsored by RAND.
NCT03874585 is a Phase 1 study of Cigarette Smoking that has completed, run by RAND. The registered enrollment target is 77 participants, below the 174-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (56% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03874585, a Phase 1 study of Cigarette Smoking, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 77 participants
- Enrollment target
- 3
- Study locations
Study Summary
Unaccompanied homeless youth smoke at much higher rates than non-homeless adolescents and young adults. Many homeless youth smokers are motivated to quit; yet, strategies specifically developed for this vulnerable population are lacking. This study will develop and pilot test a text messaging intervention (also known as a TMI) to help homeless youth quit smoking. Text messaging can provide ongoing support for homeless youth during a quit attempt, which is important given that these youth tend to be highly mobile and lack regular access to health services. Participants in this study will be homeless youth who currently smoke and are motivated to quit smoking. All participants will receive a 30-minute group-based smoking cessation counseling session and a nicotine replacement product. Half of these smokers will also receive the TMI, for 6 weeks following the group counseling session, which will provide ongoing support for quitting. The main goal of this study is to investigate whether receiving the TMI results in greater reductions in cigarette smoking over a 3-month period compared to receiving the group counseling session alone.
Primary Outcome
Participants will self-report whether they have smoked any cigarettes between baseline and 3-month follow-up
Conditions Studied
Interventions
- BEHAVIORAL Group counseling and nicotine replacement
- BEHAVIORAL Group counseling, nicotine replacement, and text messaging support
Study Locations (3)
California
- My Friend's Place - Los Angeles
- Los Angeles LGBT Center Youth Center - Los Angeles
- Safe Place for Youth - Venice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2019-05-30 |
| Est. Completion | 2020-05-21 |
| Phase | Phase 1 |
What the finished NCT03874585 record still lists
NCT03874585 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 174-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Cigarette Smoking appearing as the primary indexed condition, and to 2 interventions - of which Group counseling and nicotine replacement is the first listed.
NCT03874585 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03874585 about?
NCT03874585 is a clinical study titled "Text Messaging-Based Smoking Cessation Program for Homeless Youth". Unaccompanied homeless youth smoke at much higher rates than non-homeless adolescents and young adults. Many homeless youth smokers are motivated to quit; yet, strategies specifically developed for this vulnerable population are lacking. This study will develop and pilot test a text messaging interv...
What is the current status of trial NCT03874585?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 77 participants. The study started on 2019-05-30. Estimated completion is 2020-05-21.
What conditions does trial NCT03874585 study?
This clinical trial studies the following conditions: Cigarette Smoking.
What interventions are being tested in trial NCT03874585?
The interventions under investigation include: Group counseling and nicotine replacement (BEHAVIORAL), Group counseling, nicotine replacement, and text messaging support (BEHAVIORAL).
Who is sponsoring clinical trial NCT03874585?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03874585 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03874585's enrollment target sits among peer trials
77 25th of 45 higher than 20 of 45 other Cigarette Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cigarette Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Cannabis on Cigarette Use Behavior
RECRUITING · Phase 1
-
Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use
RECRUITING · Phase 1
-
Contingency Management, Quitting Smoking, and ADHD
COMPLETED · Phase 1
-
A Study of Inhalation of 20,000 EU CCRE and Mucociliary Clearance (MCC) in Otherwise Healthy Individuals Who Are Current Cigarette Smokers
COMPLETED · Phase 1
-
New Approaches to Smoking Cessation in Heavy Drinkers
COMPLETED · Phase 1
-
Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI